Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15878100.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concurrent vinablastine-based radiochemotherapy was evaluated in 84 bladder-cancer patients. It was effective in more than half: tumour-specific survival (51% 9-year), local control rate (55% 9-year). The drawback was the impaired function of the bladder (9-year prevalence SOMA G3-4 symptoms: 66%), indicating the need for treatment aimed at reducing chronic morbidity.
Medical subject headings
- Antineoplastic Agents, Phytogenic
- Urinary Bladder Neoplasms
- Vinblastine